HeartSciences

Heart Test Laboratories is a medical technology company focused on applying AI-based innovative technologies to electrocardiograms (ECGs) to expand and enhance the clinical utility of ECGs. Our goal is to make the ECG a more valuable tool for cardiac screening. HeartSciences' first FDA-approved product candidate, MyoVista wavECG, is a resting 12-lead ECG.